Loading stock data…
$3.33-0.25 (-7.10%)
SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States.
SeaStar Medical Holding Corporation in the Healthcare sector is trading at $3.33 with a market capitalization of $18M. Wall Street consensus targets $10.00 (2 analysts), implying a +199.9% move over the next 12 months. The stock is currently 55% below its 52-week high of $7.35, remaining 0.5% above its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 65/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $615,000↑ | $495,000↑ | $420,000↑ | $183,000↓ | $338,000 |
| Gross Profit | $561,000↑ | $449,000↑ | $408,000↑ | $169,000↓ | $311,000 |
| Operating Income | -$3.79M↓ | -$3.60M↓ | -$3.02M↑ | -$3.58M↓ | -$1.76M |
| Net Income | -$3.73M↓ | -$3.52M↓ | -$2.90M↑ | -$3.47M↓ | -$2.00M |
SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic de...